Tocilizumab

Category: Arthritis



Tocilizumab Overview

Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. It...

Read more Tocilizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tocilizumab

Recent Tocilizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tocilizumab
  • Injection: 162mg/0.9ml, 200mg/10ml, 400mg/20ml, 80mg/4ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tocilizumab: (1 result)

Sorted by National Drug Code
  • 50242-143 Actemra Actpen 180 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.

Other drugs which contain Tocilizumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA